21 closest matches · ranked by relevance
Tinea Corporis
Primary: Circulating Plasma Concentration of Luliconazole at Day 7 (Pre-Dose) — 4.63; NA nanograms/milliliter (ng/mL)
Tinea Pedis · Tinea Cruris
Primary: Naftifine Hydrochloride Pharmacokinetics Variables, Single and Multiple Dose — 138262.2; 15890.1; 68634.2; 17213.9 h*pg/mL
Tinea Versicolor
Primary: Molecular Diagnostic qPCR Comparison of DBI-002 Drug Product and Malassezia (Fungal Cause of Tinea Versicolor) — 2; 4; 5; 1 Participants — p=0.2
Tinea Versicolor
Primary: The Effect of Ketoconazole 2% Foam for the Treatment of Tinea Versicolor — 7; 4 participants
Tinea Pedis
Primary: Primary Efficacy Endpoint: The Number of Patients in Each Treatment Group With a Therapeutic Cure of Tinea Pedis (Equivalence: Per-Protocol Population) — 89; 90…
Tinea Cruris · Jock Itch
Primary: Percentage of Subjects — 25.3; 2.8 percentage of subjects with complete cur — p=0.025
Tinea Pedis
Primary: Effective Treatment Outcome (Direct Microscopy and Culture Negative and Total Signs and Symptom Score Less or Equal to 2) — 73; 10 participants
Onychomycosis · Tinea Pedis
Primary: Dermatophyte Species Distribution — 50; 37; 5; 12 isolates
Tinea Pedis
Primary: Proportion of Patients in Each Active Treatment Group Who Are Considered a Therapeutic Cure — 96; 81 Participants
Tinea Pedis · Athlete's Foot
Primary: Percentage of Subjects With Complete Cure at Week 6. — 17.7; 7.1; 16.1; 3.1 percentage of subjects with complete cur — p=0.010
Tinea Pedis
Primary: Percentage of Subjects With Therapeutic Cure at 42 Days for All-analysis Population — 2; 1; 3; 0 Participants
Tinea Pedis
Primary: Therapeutic Cure - Superiority Analysis — 76; 108; 24 Participants — p=0.0127
Tinea Pedis
Primary: Safety Evaluation Cohort 1 — 8; 0; 0; 0 Feet
Tinea Pedis
Primary: Complete Cure of Interdigital Tinea Pedis — 16.8; 1.7 percentage of subjects — p=<0.025
Tinea Pedis
Primary: Complete Cure of Interdigital Tinea Pedis — 26.0; 3.3 percentage of subjects — p=<0.025
Tinea Pedis
Primary: Proportion of Subjects in Each Treatment Group With Therapeutic Success — 70; 95; 3 participants
Tinea Pedis · Athlete's Foot
Primary: Complete Cure — 63; 81; 19; 2 Participants
Tinea Pedis · Tinea Cruris
Primary: Measurement of Circulating Plasma Levels of Luliconazole in Participants Who Had Tinea Pedis: Maximum Observed Plasma Concentration (Cmax) of Luliconazole — 3.27…
Hypersensitivity
Primary: Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Enrolled Subjects — 2182; 2 Test site
Tinea Pedis
Primary: Proportion of Subjects in Each Treatment Group With Therapeutic Success — 93; 88; 7 participants
Psoriasis Vulgaris · Topical Administration
Primary: Investigator's Static Global Assessment Scale (ISGA) Scores — 1.46; 2.02; 2.57; 2.60 Score